These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25402379)

  • 1. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome.
    Savic-Radojevic A; Bozic Antic I; Coric V; Bjekic-Macut J; Radic T; Zarkovic M; Djukic T; Pljesa-Ercegovac M; Panidis D; Katsikis I; Simic T; Macut D
    Hormones (Athens); 2015; 14(1):101-8. PubMed ID: 25402379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS) - an insight from non-obese and non-insulin resistant adolescents.
    Savić-Radojević A; Mažibrada I; Djukić T; Stanković ZB; Plješa-Ercegovac M; Sedlecky K; Bjekić-Macut J; Simić T; Mastorakos G; Macut D
    Endokrynol Pol; 2018; 69(4):366-374. PubMed ID: 29952411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome.
    Kurdoglu Z; Ozkol H; Tuluce Y; Koyuncu I
    J Endocrinol Invest; 2012 Mar; 35(3):317-21. PubMed ID: 21521935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.
    Macut D; Simic T; Lissounov A; Pljesa-Ercegovac M; Bozic I; Djukic T; Bjekic-Macut J; Matic M; Petakov M; Suvakov S; Damjanovic S; Savic-Radojevic A
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):451-5. PubMed ID: 21667435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1508-12. PubMed ID: 16464947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Kouli C; Alexandraki K; Spina G
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1273-6. PubMed ID: 15001622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
    Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
    J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
    Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
    Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
    Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
    Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
    Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.